Kinase shRNA screening reveals that TAOK3 enhances microtubule-targeted drug resistance of breast cancer cells via the NF-κB signaling pathway

BACKGROUND: Chemotherapy is currently one of the most effective treatments for advanced breast cancer. Anti-microtubule agents, including taxanes, eribulin and vinca-alkaloids are one of the primary major anti-breast cancer chemotherapies; however, chemoresistance remains a problem that is difficult...

Descripción completa

Detalles Bibliográficos
Autores principales: Lai, Tsung-Ching, Fang, Chih-Yeu, Jan, Yi-Hua, Hsieh, Hsiao-Ling, Yang, Yi-Fang, Liu, Chun-Yu, Chang, Peter Mu-Hsin, Hsiao, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7579951/
https://www.ncbi.nlm.nih.gov/pubmed/33087151
http://dx.doi.org/10.1186/s12964-020-00600-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7579951/
https://www.ncbi.nlm.nih.gov/pubmed/33087151
http://dx.doi.org/10.1186/s12964-020-00600-2

Ejemplares similares